An independent MP likely to face court after allegedly testing positive to cannabis in a roadside test says he wasn't driving ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...

Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Inc. (TSX: ACB) reported strong results in its fiscal Q2 2025 earnings, posting a 29% year-over-year increase in total revenue, reaching $81.1 million compared to $63.1 million in ...

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

In the Australian state of Victoria, a trial has commenced investigating the impacts of medicinal cannabis on driving ability ...

Traces of cannabis detected in drivers who are prescribed the drug will no longer automatically cost them their licence under ...

A report tabled in Victoria's Parliament has recommended courts be given more discretion with regard to medicinal cannabis ...

As cannabis use rises, doctors warn of a surge in cannabinoid hyperemesis syndrome (CHS), causing severe nausea and vomiting.

Around the world, the debate continues about how to quantify the presence of cannabis in an individual’s system and how it ...